Delayed-type hypersensitivity skin testing using third variable loop peptides identifies T lymphocyte epitopes in human immunodeficiency virus-infected persons

J Infect Dis. 1997 Oct;176(4):1085-9. doi: 10.1086/516517.

Abstract

Cellular immune responses to human immunodeficiency virus type 1 (HIV-1) infection, particularly in vivo responses, have been difficult to study in large patient cohorts because of technical impediments. By use of small peptide fragments of the HIV-1 gp120 third variable loop, the CD4 T lymphocyte epitopes of 2 HIV-infected persons were mapped using a cutaneous delayed-type hypersensitivity (DTH) assay. The in vivo DTH responses correlated with epitopes previously identified in vitro using CD4 T lymphocyte lines. The ability to determine CD4 T lymphocyte epitopes in large cohorts of patients using this simple in vivo technique would provide important diagnostic and prognostic data regarding effective immunoregulation of HIV-1. This technique should have broad applicability in HIV vaccine development and in the investigation of other immune-mediated human diseases.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Amino Acid Sequence
  • CD4 Antigens / analysis*
  • CD4 Antigens / immunology
  • CD4-Positive T-Lymphocytes / cytology
  • CD4-Positive T-Lymphocytes / immunology*
  • Cell Division
  • Cells, Cultured
  • Epitope Mapping / methods*
  • Female
  • HIV Envelope Protein gp120 / immunology*
  • HIV Infections / immunology*
  • HIV-1*
  • Humans
  • Hypersensitivity, Delayed / immunology
  • Leukocytes, Mononuclear / immunology
  • Male
  • Molecular Sequence Data
  • Skin Tests / methods

Substances

  • CD4 Antigens
  • HIV Envelope Protein gp120